Propranolol in migraine
Sewing, K.F.
Deutsche Medizinische Wochenschrift 104(47): 1663
1979
ISSN/ISBN: 0012-0472 PMID: 510191 Document Number: 141477
Document emailed within 1 workday
Related Documents
Ahuja, G.K.; Verma, A.K. 1985: Propranolol in prophylaxis of migraine Indian Journal of Medical Research 82: 263-265Pita, E.; Higueras, A.; Bolaños, J.; Pérez, N.; Mundo, A. 1977: Propranolol and migraine. A clinical trial Archivos de Farmacologia Y Toxicologia 3(3): 273-278
Israil, A.; Ahmed, S.; Rahman, K.M.; Uddin, M.J.; Dey, S.K.; Battacharjee, M.; Mondal, G.; Ali, M.A.; Alam, M.N.; Miah, A.H.; Uddin, M.S. 2013: Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine Mymensingh Medical Journal: Mmj 22(1): 93-100
Olness, K.; MacDonald, J.T.; Uden, D.L. 1987: Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine Pediatrics 79(4): 593-597
Maissen, C.P.; Ludin, H.P. 1991: Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine Schweizerische Medizinische Wochenschrift 121(43): 1585-1590
Pradalier, A.; Serratrice, G.; Collard, M.; Hirsch, E.; Feve, J.; Masson, M.; Masson, C.; Dry, J.; Koulikovsky, G.; Nguyen, G. 1990: Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo Therapie 45(5): 441-445
Albani, F.; Riva, R.; Cortelli, P.; Contin, M.; Baruzzi, A. 1985: Propranolol plasma binding and serum lipids during chronic therapy in migraine patients International Journal of Clinical Pharmacology Therapy and Toxicology 23(5): 267-269
Gerber, W.D.; Schellenberg, R.; Thom, M.; Haufe, C.; Bölsche, F.; Wedekind, W.; Niederberger, U.; Soyka, D. 1995: Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study Functional Neurology 10(1): 27-35
Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353
Murakami, E.; Shiosaka, S.; Tohyama, M. 1981: Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors? Cellular and Molecular Biology Including Cyto-Enzymology 27(2-3): 133-137
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Ongcharit, C.; Tungsanga, K. 1977: Propranolol and propranolol with thiazide in hypertensive Thai patients Journal of the Medical Association of Thailand 60(10): 465-469
Sjaastad, O.; Bovim, G.; Stovner, L.J. 1992: Laterality of pain and other migraine criteria in common migraine. a comparison with cervicogenic headache Functional Neurology 7(4): 289-294
Shimizu, T.; Suzuki, N. 2008: Recent topics on migraine: issues of the current treatments and new drugs for the treatment of migraine Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 131(3): 210-214
Castillo, J.; Martínez, F.; Corredera, E.; Lema, M.; Noya, M. 1995: Migraine and histamine: determining histidine in plasma and cerebrospinal fluid during migraine attacks Revista de Neurologia 23(122): 749-751
Rascol, A.; Cambier, J.; Guiraud, B.; Manelfe, C.; David, J.; Clanet, M. 1980: Cerebral ischemic accidents during migraine attacks. A report on "complicated migraine" Revue Neurologique (Paris) 135(12): 867-884
Sjaastad, O.; Bovim, G.; Stovner, L.J. 1993: Common migraine ("migraine without aura"): localization of the initial pain of attack Functional Neurology 8(1): 27-32
Antonello, R.; Cazzato, G.; Zorzon, M.; Torre, P.; Decchi, B. 1987: Migraine crisis and neurological focal signs of slow or absent resolution (complicated migraine) Rivista di Neurologia 57(6): 346-349
Vetvik, K.G.øt.; MacGregor, E.A.; Lundqvist, C.; Russell, M.B.ør. 2014: Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura Journal of Headache and Pain 15: 30
Vetvik, K.G.øt.; MacGregor, E.A.; Lundqvist, C.; Russell, M.B.ør. 2014: Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura Journal of Headache and Pain 15: 30